发表文章：

1、 张宁, 周利群, 杜鹏. 各种前列腺癌根治术式的发展特点及并发症. 中华泌尿外科杂志, 2003, 24(4): 282-284

2、 龚侃, 张宁, 那彦群. 多房囊性肾细胞癌的诊断和治疗分析. 中华医学杂志, 2004, 84(9): 740-742.

3、 张宁, 龚侃, 果宏峰, 那熙, 吴关, 杨新宇, 辛殿旗, 那彦群. 散发性肾透明细胞癌组织中VHL基因突变与血管内皮生长因子表达及其与微血管形成的关系. 中华医学杂志, 2004, 84(19): 1620-1624.

4、 龚侃, 张宁, 果宏峰, 张志文, 辛殿旗, 那彦群. 非遗传性肾透明细胞癌中VHL抑癌基因的突变及其意义. 北京大学学报（医学版）, 2004, 36（2）：169-172.

5、 龚侃, 张宁, 辛钟成, 曾荔, 林桂亭, 那彦群. 阴茎上皮样肉瘤1例报告. 中华男科学, 2004, 10(3):205-207.

6、 张宁, 李朝争, 龚侃, 李宁忱, 那彦群. 多房囊性肾细胞癌手术治疗的预后特点分析. 中华泌尿外科杂志, 2005, 26(4): 253-255.

7、  龚侃, 张宁, 那熙, 吴关, 杨新宇, 辛殿旗, 那彦群.  散发性肾透明细胞癌组织中希佩尔-林道基因突变与缺氧诱导因子1α、2α的测定. 中华外科杂志, 2005, 43(6): 390-393.

8、 刘宁, 龚侃, 张宁, 果宏峰, 那熙, 吴关, 那彦群. 肾细胞癌患者抑癌基因VHL双等位基因失活的测定. 中华泌尿外科杂志,2005, 43(2): 115-118.

9、  张宁, 龚侃, 杨勇, 那彦群. 阴囊Paget病的治疗和预后（附23例报告）. 中华男科学杂志, 2006, 12（12）：1102-1104.

10、             张宁, 龚侃,杨新宇, 辛殿旗, 那彦群. 缺氧诱导因子和血管内皮生长因子在非遗传性肾透明细胞癌中的表达及意义. 中华医学杂志, 2006, 86(22): 1526-1529.

11、             Gong K,Zhang N(共同第一),Zhang Z, Na Y. Coexpression of erythopoietin and erythopoietin receptor insporadic clear cell renal cell carcinoma. Cancer Biol Ther, 2006, 5(6):582-5.

12、             张宁, 龚侃, 周利群, 杨勇, 那彦群. 双侧散发性肾癌的外科治疗与预后观察. 中华外科杂志, 2007, 45(2): 121-123.

13、             杨勇, 严秋哲, 张宁, 牛亦农, 杜鹏. 乙状结肠膀胱扩大术治疗神经原性低顺应性膀胱的疗效观察. 中华泌尿外科杂志, 2007, 28（5）：294-297.

14、             张宁, 龚侃, 果宏峰, 杨勇, 那彦群. Von Hipple-Lindau基因突变与散发性肾透明细胞癌患者预后的关系. 中华泌尿外科杂志, 2008, 29(11): 740-743.

15、             Gong K,Zhang N（共同第一）, He Z, Zhou L, Lin G, Na Y. Multilocularcystic renal cell carcinoma: an experience of clinical management for 31 cases.J Cancer Res Clin Oncol, 2008, 134(4):433-437.

16、             张小东, 尹航, 张宁, 张勇, 杨勇. Studer回肠膀胱的远期排尿功能和并发症的临床研究. 中华泌尿外科杂志, 2008, 46(20): 1536-1538.

17、             张宁, 张鹏, 王飚, 张小东, 杨勇. 药物联合治疗膀胱疼痛综合征/间质性膀胱炎的疗效及影响因素. 中华泌尿外科杂志, 2009, 30(7): 465-468.

18、             张宁. 培养生物医学研究生撰写文章的思路. 中国医疗器械信息2010,16(3): 73-75.

19、             吴栗洋, 程浩, 邓小虎, 善辉, 王伟, 杨勇, 张小东, 张宁（通讯作者）. 血管内皮生长抑制因子在散发性肾透明细胞癌中的表达及意义. 中华医学杂志, 2013, 93（10）：741-745.

20、             Zhang N, Sanders AJ, Ye L, Kynaston HG, Jiang WG. Vascular endothelial growthinhibitor, expression in human prostate cancer tissue and the impact onadhesion and migration of prostate cancer cells in vitro. Int JOncol, 2009, 35(6):1473-1480.

21、             Zhang N, Sanders AJ, Ye L, Jiang WG. Vascular endothelial growth inhibitorin human cancer (Review). Int J Mol Med, 2009, 24(1):3-8.

22、             Zhang N, Sanders AJ, Ye L, Kynaston HG, Jiang WG. Expression of vascular endothelialgrowth inhibitor (VEGI) in humanurothelial cancer of the bladder and its effects on the adhesion and migrationof bladder cancer cells in vitro. Anticancer Res, 2010, 30(1):87-95.

23、             Zhang N, Gong K, Zhang X, Yang Y,Na Y. Extramammary Paget's disease of scrotum--report of 25 cases andliterature review. Urol Oncol, 2010, 28(1):28-33.

24、             Gong K,Zhang N（共同第一）, Zhang K, Na Y. The relationship of erythropoietinoverexpression with von Hippel-Lindau tumour suppressor gene mutations betweenhypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.Int J Mol Med, 2010, 26(6):907-912.

25、             Ning Zhang, Peng Zhang, Xiaodong Zhang, Yong Yang. The efficacy of resiniferatoxin in prevention of catheter relatedbladder discomfort in patients after TURP - A pilot, randomized, open study. Transl Androl Urol, 2012, 1(1):14-18.

26、             Wu P, Zhang N（共同第一）,Wang X, Zhang C, Li T, Ning X, Gong K. The erythropoietin/erythropoietinreceptor signaling pathway promotes growth and invasion abilities in humanrenal carcinoma cells. PLoS One, 2012;7(9):e45122.

27、             Chen S,Zhang HY, Zhang N, Li WH, Shan H, LiuK, Yang Y. Treatment for chronic ischaemia-induced bladder detrusordysfunction using bone marrow mesenchymal stem cells: an experimental study. Int J Mol Med, 2012,29(3):416-422.

28、             Wu P, Zhang N（共同第一）, Wang X, Ning X, Li T, Bu D, Gong K. Family history of von Hippel-Lindaudisease was uncommon in Chinese patients: suggesting the higher frequency of denovo mutations in VHL gene in these patients. J Hum Genet, 2012,57(4):238-243.

29、             ZhangN, Wu P, Shayiremu D, Wu L, Shan H, Ye L, Zhao X, Cai J, Jiang WG, Gong K, YangY. Suppression ofrenal cell carcinoma growth in vivo by forced expression of vascularendothelial growth inhibitor. Int J Oncol, 2013, 42(5):1664-1673.

30、             ZhangN, Wu P, Wu L, Shayiremu D, Shan H, Ye L, Jiang WG, Gong K, Yang Y. The differential expression of vascularendothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in humanclear-cell renal cell carcinoma. Cancer Genomics Proteomics, 2013, 10(1):47-53.

31、             Wang M,Zhang N, Wang W, Wang B, Xu Z, YangY. Expression andfunction of vascular endothelial growth inhibitor in aged porcine bladderdetrusor muscle cells. Biogerontology, 2013, 14(5):543-556.

32、             Zhang N, Ye L, Wu L, Deng X, YangY, Jiang WG.Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancerof the bladder and its effects on the aggressiveness of bladder cancer cells invitro. AnticancerRes, 2013, 33(5):1917-1925.

33、             Zhang N, Zhang XD. Controversy ofthe prostate-specific antigen test era: should prostate cancer be detected and treated in all patients?Chin Med J (Engl), 2013, 126(15):2803-2804.

34、             Wu L,Li X, Ye L, Shayiremu D, Deng X, Zhang X, Jiang W, Yang Y, Gong K, Zhang N（通讯作者）.Vascular endothelial growth inhibitor174 is a negative regulator of aggressiveness and microvascular density inhuman clear cell renal cell carcinoma. Anticancer Res, 2014,34(2):715-22.

35、             ZhangP, Yang Y, Wu ZJ, Zhang N, Zhang CH,Zhang XD. Long-term follow-up of sigmoid bladder augmentation forlow-compliance neurogenic bladder. Urology, 2014, 84(3): 697-701.

36、             ZhangP, Wu ZJ, Xu L, Yang Y, Zhang N,Zhang XD. Bladder neckincision for female bladder neck obstruction: long-term outcomes.Urology, 2014, 83(4):762-6.

37、             张宁. 泌尿内镜检查教学中的素质教育与健康性认知教育. 中国性科学, 2014, 23(1): 17-19.

38、             丁文京, 张宁（通讯作者）. 无针吊带技术在治疗女性压力性尿失禁的临床应用研究. 中国性科学, 2014, 23(1):28-30

39、             洪保安, 张小东, 邢念增, 张宁（通讯作者）. 微波消融治疗肾癌的研究进展. 临床泌尿外科杂志, 2014, 29(5):448-451.

40、             洪保安，杜鑫，陈国伟，张小东，邢念增，王玮，王飚，张鹏，张际青，张宁（通讯作者）.微波消融治疗肾脏肿瘤的适应证选择.临床泌尿外科杂志，2015,29（3）：200-203.

41、             洪保安，陈国伟，赵媛，杜鑫，杨勇，张小东，邢念增，张宁（通讯作者）.应用离体猪肾脏模型探索微波消融治疗肾脏肿瘤的消融范围和特点. 中华医学杂志， 2015，95（32）:2644-2646

42、             ChenS, Huang Q, Liu J, Xing J, Zhang N, Liu Y, Wang Z, Li Q. A targeted IL-15fusion protein with potent anti-tumor activity. Cancer Biol Ther. 2015 Sep2;16(9):1415-21

43、             Huang Q, Zhou C, Chen X,Dong B, Chen S, Zhang N, Liu Y, Li A, Yao M, Miao J, Li Q, Wang Z. Prodrug AST-003 Improves theTherapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib.PLoS One. 2015 Oct 29;10(10):e0141395.

44、              Li L, He P, Zhou C,Jing L, Dong B, Chen S, Zhang N, Liu Y, Miao J, Wang Z, Li Q. A novel bispecific antibody, S-Fab,induces potent cancer cell killing. J Immunother. 2015Nov-Dec;38(9):350-6.

45、             Li L, He P, Zhou C, Jing L, Dong B, Chen S, Zhang N, Liu Y, Miao J, Wang Z, Li Q. A NovelBispecific Antibody, S-Fab, Induces Potent Cancer Cell Killing. J Immunother. 2015Nov-Dec;38(9):350-6.

46、             Baoan Hong, Xin Du, Yuan Zhao, Guowei Chen, XiaodongZhang, Ning Zhang* & Yong Yang*. Characteristics of laparoscopicmicrowave ablation with renal tissue: Experimental in vivo study using a porcinemodel. Int J Hyperthermia, 2015Dec;31(8):930-6. 

47、             Ning Zhang, Baoan Hong,Changhua Zhou, Xin Du, Siqi Chen, Xiaohu Deng, Shayiremu Duoerkun, Qing Li,Yong Yang, and Kan Gong. Cobalt Chloride-induced Hypoxia Induces Epithelial-mesenchymalTransition in Renal Carcinoma Cell Lines. AnnClin Lab Sci. 2017 Jan; 47(1):40-46.

48、             BaoanHong, Yong Yang, Sheng Guo, Shayiremu Duoerkun, Xiaohu Deng, Dawei Chen, ShijunYu, Wubin Qian, Qixiang Li, Qing Li, Kan Gong and NingZhang. Intra-tumour molecular heterogeneity of clear cell renal cellcarcinoma reveals the diversity of the response to targeted therapies usingpatient-derived xenograft models. . Oncotarget, 2017, 25;8 (30): 49839-50

49、             Ning Zhang, Baoan Hong, Wenyong Lian, Changhua Zhou, Siqi Chen, XinDu, Xiaohu Deng, Shayiremu Duoerkun, Qing Li, Yong Yang, and Kan Gong. Vascular endothelial growth inhibitor 174 andits functional domains inhibit epithelial-mesenchymal transition in renal cellcarcinoma cells in vitro.IJMM, 2017, Aug;40(2):569-575.

50、             Zhao Q, Kun D, Hong B, Deng X, Guo S, Tang X, Yang Y, Gong K, Li Q, Ye L, Jiang WG, ZhangN. Identificationof Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 inRenal Cell Carcinoma. Anticancer Res, 2017, 37(8):4379-4388.

51、             Zhao Q, Deng X, Hong B, Wang F, Tang X, Yang Y, Gong K, Ye L, Jiang WG, ZhangN. Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial-MesenchymalTransition in Renal Cell Carcinoma In Vivo. AnticancerRes, 2017, 37(8):4269-4275.

52、             赵强，多尔坤，杨勇，杜鹏，曹煜东，王硕，刘佳，汤星星，纪永鹏，张宁. 巨大肾血管平滑肌脂肪瘤行保留肾单位的适应证和手术经验. 中华泌尿外科杂志,2018,39(5) : 347-350.

53、             赵强，杨勇，李莉，杜鹏，王硕，汤星星，安超，纪永鹏，张宁. 局部治疗对激素敏感性转移性前列腺癌预后影响的Meta分析. 中华泌尿外科杂志, 2017，38(10) :  791-796.

54、             Zhao Q1,Liu T, Hong B, Wang F, Zhou C, Du X, Chen S, Deng X, Duoerkun S, Li Q, Yang Y, Gong K, Zhang N. Vascular Endothelial Growth Inhibitor, a Cytokine ofthe Tumor Necrosis Factor Family, is Associated With Epithelial-MesenchymalTransition in Renal Cell Carcinoma. ApplImmunohistochem Mol Morphol. 2018 Nov/Dec;26(10):727-733.

55、             Zhao Q1, HongB2, LiuT3, JiY1, TangX1, GongK2, YeL4, YangY1, ZhangN1. VEGI174 protein and its functional domain peptides exert antitumour effects on renal cell carcinoma.Int J Oncol, 2019, 54: 390-398.

56、             HongB1, Cai L1, Wang J1, Liu S1, Zhou J1, Ma K1, ZhangJ1, Zhou B1, Peng X1, ZhangN2, GongK3.Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-CellRenal Cell Carcinoma andIts Correlation With Clinicopathological Features. Clin Genitourin Cancer. 2018 Nov 13.  pii: S1558-7673(18)30272-6

57、             WangY, Liu Y, Zhou C, Wang C, Zhang N, Cao D, Li Q, Wang Z. AnAKR1C3-specific prodrug with potent anti-tumor activities against T-ALL. LeukLymphoma, 2020: 1-9.

58、             LiuC, Liu T, Zhang Z, Zhang N, Du P, Yang Y, Liu Y, Yu W, Li N,Gorin M A, Rowe S P, Zhu H, Yan K, Yang Z P. PSMA PET/CT and standard plusPET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinicallysignificant prostate cancer in men with previous negative biopsies. J Nucl Med,2020.

59、             ShanH, Zhang E W, Zhang P, Zhang X D, Zhang N, Du P, Yang Y.Differential expression of histamine receptors in the bladder wall tissues ofpatients with bladder pain syndrome/interstitial cystitis - significance in theresponsiveness to antihistamine treatment and disease symptoms. BMC Urol, 2019,19(1): 115.

60、             HongB, Ma K, Zhou J, Zhang J, Wang J, Liu S, Zhang Z, Cai L, Zhang N,Gong K. Frequent Mutations of VHL Gene and the Clinical Phenotypes in theLargest Chinese Cohort With Von Hippel-Lindau Disease. Front Genet, 2019, 10:867.

61、             HongB, Zhang Z, Zhou J, Ma K, Zhang J, Cai L, Zhang N, Gong K.Distinctive clinicopathological features of Von Hippel-Lindau-associatedhereditary renal cell carcinoma: A single-institution study. Oncol Lett, 2019,17(5): 4600-4606.

62、             HongB, Zhou J, Ma K, Zhang J, Xie H, Zhang K, Li L, Cai L, Zhang N,Zhang Z, Gong K. TRIB3 Promotes the Proliferation and Invasion of Renal CellCarcinoma Cells via Activating MAPK Signaling Pathway. Int J Biol Sci, 2019,15(3): 587-597.

63、             HongB, Cai L, Wang J, Liu S, Zhou J, Ma K, Zhang J, Zhou B, Peng X, Zhang N,Gong K. Differential Expression of PD-L1 Between Sporadic and VHL-AssociatedHereditary Clear-Cell Renal Cell Carcinoma and Its Correlation WithClinicopathological Features. Clin Genitourin Cancer, 2019, 17(2): 97-104.

64、             LiuC, Liu T, Zhang N, Liu Y, Li N, Du P, Yang Y, Liu M, Gong K, YangX, Zhu H, Yan K, Yang Z. (68)Ga-PSMA-617 PET/CT: a promising new technique forpredicting risk stratification and metastatic risk of prostate cancer patients.Eur J Nucl Med Mol Imaging, 2018, 45(11): 1852-1861.

65、             赵强，刘辰，刘佳，汤星星，纪永鹏，曹煜东，洪保安，刘特立，杨志，杜鹏，杨勇，张宁. 68Ga-PSMA PET-CT检查中SUVmax与前列腺癌患者临床病理特点的相关性分析[J]. 中华泌尿外科杂志,2020,41(1):13-18.

66、             杜鑫，洪保安，赵强，纪永鹏，杨勇，张宁. 肾癌循环肿瘤细胞检测及临床应用的研究进展[J]. 中华泌尿外科杂志,2020,41(2):153-156.

67、             刘佳，曹煜东，汤星星，王硕，杨勇，张宁，杜鹏. 检测循环肿瘤细胞对预测尿路上皮癌淋巴结转移的价值[J]. 中华泌尿外科杂志,2019,40(12):885-888.

68、             刘辰，刘特立，杨志，张宁，杜鹏，杨勇，刘毅强，王静，严昆，杨兴，朱华，李囡. 68Ga-PSMA-617PET/CT对高危前列腺癌的预测价值[J].中华核医学与分子影像杂志,2019,39(2):77-80.

69、             刘畅，张宁. 从VEGF和sVEGFR2探究分子靶向药物舒尼替尼治疗转移性肾癌的机制[J]. 现代泌尿外科杂志,2019,24(4):309-313.

70、             洪保安，王江宜，刘圣杰，张九丰，周靖程，马开访，张宁，龚侃. 双侧肾癌相关的分子学研究进展[J]. 中华医学杂志,2018,98(8):638-640.

71、             中国von Hipple-lindau病诊治专家共识，编委，中华医学杂志.2018,(28) :2220-2224.

72、             Qiang Zhao, Jia Xue, Baoan Hong, Wubin Qian, Tiezhu Liu, Bin Fan, Jie Cai, Yongpeng Ji , Jia Liu, Yong Yang, Qixiang Li , Sheng Guo , Ning Zhang. Transcriptomic characterization and innovative molecularclassification of clear cell renal cell carcinoma in the Chinese population.Cancer Cell Int. 2020 Sep22;20:461

73、             张宁，赵强.得时无怠——前列腺癌基因检测的时机. 中华泌尿外科杂志, 2020,41(Z1) : 5-7.

74、             洪保安, 侯惠民,陈凌霄,张志鹏,李智,杜鑫,李源,刘明, 张宁.乳头状肾细胞癌的临床病理特征及预后分析. 中华泌尿外科杂志, 2020,41(12) :896-900.

75、             赵强, 刘辰,刘佳,汤星星,纪永鹏,曹煜东,洪保安,刘特立,杨志,杜鹏,杨勇,张宁. 68Ga-PSMAPET-CT检查中SUVmax与前列腺癌患者临床病理特点的相关性分析. 中华泌尿外科杂志, 2020,41(01) : 13-18.

76、             杜鑫, 洪保安,赵强,纪永鹏,杨勇,张宁. 肾癌循环肿瘤细胞检测及临床应用的研究进展. 中华泌尿外科杂志, 2020,41(02) :153-156.

77、             LiuC, Liu T, Zhang Z, Zhang N, Du P, Yang Y, Liu Y, Yu W,Li N, Gorin MA, Rowe SP, Zhu H, Yan K, Yang Z. 68Ga-PSMA PET/CTCombined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose ClinicallySignificant Prostate Cancer in Men with Previous Negative Biopsy Results.J Nucl Med. 2020 Sep;61(9):1314-1319.

78、             Liu T, Liu C, Zhang Z, Zhang N, Guo X, Xia L, Jiang J, Xie Q, Yan K,Rowe SP, Zhu H, Yang Z. 64Cu-PSMA-BCH: a newradiotracer for delayed PET imaging of prostate cancer. Eur J NuclMed Mol Imaging. 2021 Jun 25.

79、             LiuC, Liu T, Zhang N,Liu Y, Li N, Du P, Yang Y, Liu M, Gong K, Yang X, Zhu H, Yan K, Yang Z. 68Ga-PSMA-617PET/CT: a promising new technique for predicting risk stratification andmetastatic risk of prostate cancer patients. Eur J Nucl Med MolImaging. 2018 Oct;45(11):1852-1861.

80、             Wang Y, Liu Y, Zhou C, WangC, Zhang N, Cao D, Li Q, Wang Z. An AKR1C3-specificprodrug with potent anti-tumor activities against T-ALL. LeukLymphoma. 2020 Jul;61(7):1660-1668.

81、             洪保安，杜鑫，纪永鹏，赵强， 曹煜东，刘佳，王硕，杜鹏，杨勇，张宁. 腹腔镜下微波消融联合肾部分切除术治疗囊性肾肿物的初步疗效观察. 中华泌尿外科杂志, 2021,42(10) :721-724.

82、             洪保安, 杜鑫, 纪永鹏, 赵强, 王硕, 刘佳, 曹煜东, 杨潇, 杜鹏, 杨勇, 张宁. 经腹腔镜微波消融联合肾部分切除术治疗肾肿瘤的安全性和疗效. 中华医学杂志, 2021, 101（46）：3794-3798.

83、             刘辰，刘特立，谢卿，张仲一，严昆，杨勇，刘毅强， 杨志，张宁.  68Ga-PSMA PET/CT显像在前列腺重复穿刺前对良恶性病变的预判价值. 中华泌尿外科杂志,2021,42(9): 712-716.

84、             Teli Liu, Chen Liu,Zhongyi Zhang, Ning Zhang, Xiaoyi Guo, Lei Xia, Jinquan Jiang, Qing Xie,Kun Yan,Steven P. Rowe, Hua Zhu, Zhi Yang. 64Cu-PSMA-BCH: a new radiotracer fordelayed PET imaging of prostate cancer[J]. European Journal of Nuclear Medicineand Molecular Imaging,2021.

85、             Baoan Hong, HuiminHou， Lingxiao Chen, Zhi Li, ZhipengZhang, Qiang Zhao, Xin Du, Yuan Li, Xiongjun Ye, Wanhai Xu, Ming Liu and NingZhang（共同通讯）. TheClinicopathological Features and Prognosis in Patients With Papillary RenalCell Carcinoma: A Multicenter Retrospective Study in Chinese Population[J].Frontiers in Oncology,2021,11.

86、             Liangtao Zheng, Shishang Qin , Wen Si, Anqiang Wang, Baocai Xing, Ranran Gao， Xianwen Ren , Li Wang, Xiaojiang Wu, Ji Zhang, Nan Wu , Ning Zhang, Hong Zheng , Hanqiang Ouyang, Keyuan Chen, Zhaode Bu, XuedaHu , Jiafu Ji, Zemin Zhang. Pan-cancersingle-cell landscape of tumor-infiltrating T cells. Science, 2021Dec 17;374(6574):abe6474.  doi:10.1126/science.abe6474. Epub 2021 Dec17

87、  原发性膀胱腺癌诊治中国专家共识. 中华医学杂志, 2022,102(44):3492-3500. 北京医学会罕见病分会, 中华医学会泌尿外科分会中国泌尿系统遗传及罕见病联盟. 张宁，通讯作者

88、  Hong B, Zhao Q, Ji Y, Ning Zhang. The safety and efficacy of laparoscopic microwave ablation-assisted partial nephrectomy: a new avenue for the treatment of cystic renal tumors. Int J Hyperthermia, 2023,40(1):2157499.

论著及译著

主编论著

肾癌的微侵袭治疗，人民卫生出版社， ISBN： 978-7-117-21098-0/R·21099

全国高等学校“器官-系统”整合教材~泌尿系统，第一版，副主编，人民卫生出版社，ISBN：9787117212168

遗传性肾癌的基础与临床，人民卫生出版社，副主编

肿瘤科普百科丛书，人民卫生出版社，执行主编

前列腺癌分册，人民卫生出版社，主编

肿瘤科普百科全书,执行主编，前列腺癌分册,主编,人民卫生出版社ISBN，978-7-117-33215-6

 参编泌尿外科专著

继发性与难治性高血压，人民卫生出版社， ISBN： 9787117347617

泌尿外科疑难病例精选，人民卫生出版社， ISBN： 978-7-117-13608-2/R·13609

下尿路修复重建手术学，人民卫生出版社， ISBN：9787117129282

泌尿外科学，人民卫生出版社，ISBN：9787117210461

全国高等学校“器官-系统”整合教材~泌尿系统，第二版，编委，人民卫生出版社

前列腺穿刺活检术，科学技术文献出版社，ISBN978-7-5189-7666-9

 主译泌尿外科专著

癌症的早期诊断和治疗-前列腺癌，人民卫生出版社， ISBN：9787117140263

 参译泌尿外科专著

肾移植手册，人民卫生出版社，ISBN：7117075147

牛津临床泌尿外科手册，人民卫生出版社， ISBN：9787117075152

女性泌尿外科学、泌尿妇科学及排尿功能障碍，人民卫生出版社， ISBN：9787117092203

坎贝尔泌尿外科学（第九版），北京大学医学出版社，ISBN：7-81116-457-2 

Smith腔内泌尿外科学(第二版)，人民卫生出版社，ISBN： 978-7-117-14319-6/R·14320

 获奖：

1.       中华医学科技奖：肾透明细胞癌致病基因的基础研究与临床应用，2015年中华医学科技奖三等奖，证书编号：201503014P802，颁奖单位：中华医学会，2015-12-21，第二完成人

2.       高等学校科学研究优秀成果奖（科学技术）：VHL 基因相关肾细胞癌的基础研究及临床应用, 2012 年度高等学校科学研究优秀成果奖（科学技术），颁奖单位：教育部科技发展中心

3.       华夏医学科技奖：肾细胞癌VHL 基因系统化研究与临床应用,2011年华夏医学科技奖二等奖，颁奖单位:中国医疗保健国际交流促进会，第二完成人

4.       2021年中国创新方法大赛北京赛区决赛，二等奖，基于TRIZ理论的“以患者为中心的智能前列腺癌全程招呼康复管理系统”，颁奖单位：北京市科委，北京工商业联合会，第一完成人

 5.   北京市科委，2022年中国创新方法大赛，北京赛区决赛三等奖，基于TRIZ理论的“男性UAH健康管理系统”，颁奖单位：北京市科委，北京工商业联合会，第一完成人